Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 2 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 23 Cisplatin 22 durvalumab 13 pembrolizumab 8 Oxaliplatin 7 Capecitabine 7 Fluorouracil 6 Leucovorin 5 Bevacizumab 5 lenvatinib 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 Nivolumab 3 Liquid Biopsy 3 Injections 3 Folfox protocol 3 zanidatamab 2 trifluridine tipiracil drug combination 2 tremelimumab 2 tislelizumab 2 ivosidenib 2 futibatinib 2 apatinib 2 Trastuzumab 2 Taxes 2 Irinotecan 2 Immune Checkpoint Inhibitors 2 Drug Therapy 2 Carboplatin 2 Blood Specimen Collection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Biliary Tract Neoplasms × DNA, Mitochondrial × Clear all

NCT06653127 2024-12-30

CCGLC-016

Tongji Hospital

Gastrointestinal

Biliary Tract Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡